JPRN-UMIN000011335
Completed
未知
Efficacy evaluation of a newly-designed partially-covered self-expandable metallic stent for malignant duodenal obstruction - A new partially-covered SEMS for duodenal obstruction
Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Toho Univerisity Ohashi Medical Center0 sites25 target enrollmentJuly 31, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Toho Univerisity Ohashi Medical Center
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Multiple obstruction of distal intestine (2\)Gastrointestinal perforation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of the effectiveness of a newly developed blended module for patients recovering from depression (STAIRS): a mixed methods RCTdepression10027946NL-OMON54416niversitair Medisch Centrum Groningen140
Not yet recruiting
Phase 4
Study of efficiency and effectiveness of a new family of introcular lensesnspecified senile cataractunspecified cataractH25.9H26.9RBR-772s6yJoão Marcelo de Almeida Gusmão Lyra
Not yet recruiting
Not Applicable
Preliminary evaluation of the effectiveness of an online-based program for the treatment of depression (Tilda Care Depression)DRKS00026641All About Me GmbH75
Active, not recruiting
Phase 1
Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in meandrogenetic alopeciaTherapeutic area: Body processes [G] - Genetic Phenomena [G05]EUCTR2014-005573-36-DEPierre Fabre Dermatologie represented by the Institut de Recherche Pierre Fabre (IRPF)
Active, not recruiting
Not Applicable
A Pilot Phase II Study for the evaluation of efficacy and tolerability of Gammaidroxybutyrate (ALCOVER) administered by oral route as add on treatmant in patients affected by DYT 11 Myoclonic Dystonia. - NDEUCTR2006-001039-23-ITISTITUTO NEUROLOGICO CARLO BESTA